Mittapalli, R. K., Vaidhyanathan, S., Dudek, A. Z., & Elmquist, W. F. (2013). Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaF(V600E) Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases. The American Society for Pharmacology and Experimental Therapeutics.
Style de citation ChicagoMittapalli, Rajendar K., Shruthi Vaidhyanathan, Arkadiusz Z. Dudek, et William F. Elmquist. Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaF(V600E) Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases. The American Society for Pharmacology and Experimental Therapeutics, 2013.
Style de citation MLAMittapalli, Rajendar K., Shruthi Vaidhyanathan, Arkadiusz Z. Dudek, et William F. Elmquist. Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaF(V600E) Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases. The American Society for Pharmacology and Experimental Therapeutics, 2013.